HemaSphere (Jun 2022)
P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
- B. Andemariam,
- J. James,
- C. Minniti,
- B. Inusa,
- F. El Rassi,
- A. Nero,
- C. Trimnell,
- M. R. Abboud,
- J.-B. Arlet,
- R. Colombatti,
- M. de Montalembert,
- S. Jain,
- W. Jastaniah,
- E. Nur,
- M. Pita,
- L. DeBonnett,
- T. Bailey,
- O. Rajkovic-Hooley,
- I. Osunkwo
Affiliations
- B. Andemariam
- 1 New England Sickle Cell Institute, Division of Hematology-Oncology, Neag Comprehensive Cancer Center, UCONN Health, University of Connecticut, Farmington, United States of America
- J. James
- 2 Sickle Cell Society, London, United Kingdom
- C. Minniti
- 3 Montefiore Health System, Albert Einstein College of Medicine, New York, United States of America
- B. Inusa
- 4 Paediatric Haematology, Evelina Children’s Hospital, Guy’s and St Thomas’ Hospital, London, United Kingdom
- F. El Rassi
- 5 Department of Hematology and Medical Oncology, Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta
- A. Nero
- 6 University of Texas Southwestern Medical Center, Dallas
- C. Trimnell
- 7 Sickle Cell 101, San Jose, United States of America
- M. R. Abboud
- 8 American University of Beirut Medical Center, Beirut, Lebanon
- J.-B. Arlet
- 9 Hôpital Européen Georges-Pompidou, Paris, France
- R. Colombatti
- 10 Clinica di Oncoematologia Pediatrica, Dipartimento della Salute della Donna e del Bambino Azienda Ospedaliera, Università di Padova, Padova, Italy
- M. de Montalembert
- 11 Hôpital Universitaire Necker-Enfants Malades, Paris, France
- S. Jain
- 12 Thalassemia And Sickle Cell Society, Hyderabad, India
- W. Jastaniah
- 13 Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
- E. Nur
- 14 Department of Clinical Hematology, Amsterdam University Medical Centers, Academic Medical Center, Amsterdam, Netherlands
- M. Pita
- 15 Department of Hematology and BMT, Samaritano Hospital, São Paulo, Brazil
- L. DeBonnett
- 16 Novartis Pharmaceuticals Corporation, East Hanover, United States of America
- T. Bailey
- 17 Adelphi Real World, Bollington, United Kingdom
- O. Rajkovic-Hooley
- 17 Adelphi Real World, Bollington, United Kingdom
- I. Osunkwo
- 18 Forma Therapeutics, Watertown, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000848724.04482.30
- Journal volume & issue
-
Vol. 6
pp. 1349 – 1350
Abstract
No abstracts available.